Provinal® is the only scientifically-studied and clinically-validated Omega-7 fatty acid of the palmitoleic class of Omega-7 fatty acids. When compared to popular Omega-3 fatty acids, Provinal®’s primary method of action signals molecules in animals and humans that facilitate healthy communication to muscle and fat cells for energy utilization and healthy fat storage and metabolism.
Provinal® lipid therapeutics have been seen to improve:
-
Cardiovascular metabolic syndrome, cardiovascular disease, coronary artery disease and the accumulation of cholesterol and lipid deposits in blood vessels.
-
Prevention and treatment of chronic dry eye syndrome, symptoms and disease.
-
Beneficial effects in glucose metabolism, obesity, insulin sensitivity and resistance, diabetes, fatty liver disease and dyslipidemia.
-
CRP – the chief biomarker for metabolic status.
Unique advantages of Provinal® are:
-
First ever ethyl ester form of fish oil to meet and be approved by the rigorous NDI notification requirements of the US FDA. MSC & GOED Certification.
-
Novel patented Omega-7 fish oil composition consisting of no less than 50% palmitoleic acid and no more than 1% of palmitic acid, a pro-inflammatory which is known to induce ER stress, inflammation, apoptosis, insulin resistance, glucose intolerance and steatosis of liver and muscle cells and tissues.
-
Currently supported by 24 issued, pending and enforceable international patents of which seven are in the US and multiple pending patents in the US and worldwide.
-
Provinal® safety and efficacy are proven by clinical and preclinical studies conducted with the same Provinal® ingredients as in all Tersus commercialized products.